Wednesday, June 7, 2017
- 1:15pm-2:45pm
-
Structural brain changes in patients with Multi System Atrophy: A VBM and DTI based study.
Neuroimaging (Non-PD) · Exhibit Hall C
- 1:15pm-2:45pm
-
Study of neuroprotective effects of Ginsenside Rg3 , the prototypal epigenetic Sirtuin-1 activator, in targeting microglia activation and neurotrophic factor (NF) neural plasticity in MPTP model of Parkinson’s disease (PD)
Neuropharmacology · Exhibit Hall C
- 1:15pm-2:45pm
-
Subcortical involvement in body and mental action processing: an electrophysiological registration study
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Subcortical involvement in phonological input processing: an electrophysiological registration study
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Subjective cognitive complaints in Parkinson’s disease patients: what should we value ?
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson’s disease
Parkinson's Disease: Cognition · Exhibit Hall C
- 1:15pm-2:45pm
-
Suicidality in Parkinson’s Disease: A Case Control Study
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
Systematic Evaluation of Major and Minor Psychotic Symptoms in Parkinson’s Disease
Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C
- 1:15pm-2:45pm
-
TANDEM REPEATS BEYOND THE CLINICAL DIAGNOSIS IN ADCAs
Ataxia · Exhibit Hall C
- 1:15pm-2:45pm
-
Targeting the intracellular localization of Ataxin-3 as novel treatment strategy for Spinocerebellar Ataxia Type 3
Ataxia · Exhibit Hall C
- «Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 38
- Next Page»